News & Updates

Children born to mothers with attention deficit/hyperactivity disorder (ADHD) who used associated medications during pregnancy do not seem to have adverse early childhood development, according to a retrospective study from the Netherlands.

Engaging in high levels of physical activity throughout adulthood may reduce the risk of dementia and preserve cognitive health.

Use of candesartan is both safe and effective, showing promise in the prevention of migraine headaches, suggests a study in the Philippines.

A large, multicohort study of cognitively unimpaired older adults has found that higher plasma p-tau217 levels are consistently associated with greater risk of progression to cognitive impairment and faster rates of cognitive decline, providing time-specific absolute risk estimates and supporting the potential of p-tau217 for prognostic model development.

A pooled analysis presented at AAIC^® 2026 demonstrated a consistent association between higher levels of plasma phosphorylated tau 217 (p-tau217) and an increased risk of clinical progression and accelerated cognitive decline in a large cohort of older adults without cognitive impairment.

O-linked N-acetylglucosaminidase inhibition with ceperognastat falls short of slowing disease progression in patients with early Alzheimer’s disease (AD), according to a phase II study.

Adherence to healthy dietary patterns offers no significant effect on the long-term risk of cognitive decline in a population-based cohort of older Singaporeans, researchers have found.